Product Information
ARMODAFINIL 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.9226 per EA under NDC 00093309456. Its NADAC has been published 502 times since Jan 11, 2017.
FDA first approved this application on Jun 15, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093309456
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ARMODAFINILApproval Type
Authorized Generic (NDA)
FDA Application
NDA021875FDA Approved
6/15/2007
TE Code
AB
On Market Since
11/29/2016
Price Statistics
The NADAC for ARMODAFINIL 250 MG TABLET has been published 502 times since Jan 11, 2017, and over the history we have for it it has declined 94.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9226 per EA |
|---|---|
| All-time high | $17.0563 (Jan 11, 2017) |
| All-time low | $0.6325 (Nov 20, 2024) |
| 52-week high | $0.9673 |
| 52-week low | $0.8651 |
| Median price | $1.0242 |
| Average price | $1.2718 |
| Largest weekly change | -86.6% (Feb 22, 2017) |
| Weeks tracked | 502 |
| Tracking since | Jan 11, 2017 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ARMODAFINIL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARMODAFINIL 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.9226 per EA (NDC 00093309456), effective Aug 19, 2026.
How has the price of ARMODAFINIL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARMODAFINIL 250 MG TABLET has declined 94.6%. It has been tracked across 502 weekly CMS publications since Jan 11, 2017.
What are the highest and lowest recorded NADAC prices for ARMODAFINIL 250 MG TABLET?
Since Jan 11, 2017, the NADAC for ARMODAFINIL 250 MG TABLET has ranged from a low of $0.6325 (Nov 20, 2024) to a high of $17.0563 (Jan 11, 2017), with a median of $1.0242 per EA.
Are there cheaper alternatives to ARMODAFINIL 250 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARMODAFINIL 250 MG TABLET, is $0.8651 per EA — about 6% below ARMODAFINIL 250 MG TABLET.
Who manufactures ARMODAFINIL 250 MG TABLET?
ARMODAFINIL 250 MG TABLET (NDC 00093309456) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.